InnovAge, Voyager Technologies And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Anglogold Ashanti shares are trading higher after Goldman Sachs initiated coverage on the stock with a Buy rating and announced a $104 price target.

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.

Goldman Sachs Initiates Coverage On Anglogold Ashanti with Buy Rating, Announces Price Target of $104

Goldman Sachs analyst Matt Greene initiates coverage on Anglogold Ashanti (NYSE:AU) with a Buy rating and announces Price Target of $104.

Shares of precious metals-related companies are trading lower after stronger-than-expected inflation data boosted expectations for a Federal Reserve rate hike in October. Gold and silver prices are declining amid a stronger U.S. dollar and rising Treasury yields, which make non-yielding precious metals less attractive to investors.

Reported October 15, 'DeepSeek offers user refunds after suffering another major outage' - SCMP

https://www.scmp.com/tech/big-tech/article/3371047/deepseek-offers-user-refunds-after-suffering-another-major-outage

Alibaba vs. Coupang: Which E-Commerce Giant Is a Better Buy in 2026?

The article compares Alibaba and Coupang as investment opportunities in 2026. Alibaba, despite facing regulatory uncertainty, AI spending pressures, and geopolitical risks, is recommended as the better buy due to its stronger profitability (10.1% net margin), attractive valuation (16.9x forward P/E), and double-digit AI cloud revenue growth. Coupang, while growing faster (14.1% YoY revenue growth), faces record regulatory fines, perjury investigations, and shareholder lawsuits with a thin 0.6% net margin, making it a riskier choice.